Philip Morris
Fields
- Author
- Cooper, T.
- Area
- CARCHMAN,RICHARD/MEZZANINE
- Type
- LETT, LETTER
- Recipient (Organization)
- Meyer Friedman Inst
- Mount Zion Medical Center of Ucsf
- Recipient
- Friedman, M.
- Document File
- 2023131044/2023131192/Missing
- Request
- Stmn/R1-009
- Litigation
- Stmn/Produced
- Author (Organization)
- Upjohn
- Named Organization
- Natl Heart Lung + Blood Inst
- Yale Norwalk
- Site
- R530
- Master ID
- 2023131143/1146
Related Documents: - Date Loaded
- 05 Jun 1998
- UCSF Legacy ID
- xie78e00
Document Images
THE UPJOHN COMPANY
7000 PORTAGE FiOAp
KAWIMAZOO. MICHIGAN 49001,0199 U S A
October 25, 1991
Meyer Friedman, M.D.
Medical Director
Meyer Friedman Institute
Mount Zion Medical Center of UCSF
P.O. Box 7921
San Francisco, CA 94120
Dear Dr. Friedman:
TMEO00pE COOPER w10
l7wm.n d+ne Aarv
ana Ohw/ fncunw daca
TELEProONE 1616)323-7m
Thanks very much for the October 21 recruiting update of your Coronary/Cancer
Prevention Project and the news that you and your associates at the Yale-Norwalk
branch have reached your 3,000 participants goal and that you have 80 percent of the
1,500 participants randomized for Type A counseling already in treatment groups.
I believe that this present study of yours will be as important, or perhaps even more so,
than your 1977 Recurrent Coronary Prevention Project which I am proud to have
supported when I was Director of the National Heart, Lung and Blood Institute. I
believe that what you and your associates did in that study clearly demonstrated that
stress does play a very important part in the pathogenesis of coronary heart disease.
Your ongoing study may prove to be even more important because it also will examine
the possible role of stress in the pathogenesis of cancer and in a statistically decisive
manner. Such a study is long overdue. So many things have been suggested as the
trigger for the release of oncogenes. Stress should certainly be included among the
factors involved.
I know that you would iike an answer to the possible role of stress in Cance-r and'
beginning heart disease. It will take not only 3,000 participants but they must be
followed, as you plan, for a number of years to obtain the hard core statistics that will
be required to validate whatever conclusions the study reveals.
I shall come to San Francisco in the not too distant future. Meanwhile, do continue to
send me ongoing data on this landmark study.
Sincerely,
~
Theodore Cooper,
msw .D., Ph.D.
